English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Multimedia Press Releases
與阿里升級戰略合作 易居全資控股天貓好房
與阿里升級戰略合作 易居全資控股天貓好房
May 7 2021, 15:23 HKT
more details
문스테이크, IOST 블록 체인과 파트너십 체결하며 IOST스테이킹 지원 예정 발표
문스테이크, IOST 블록 체인과 파트너십 체결하며 IOST스테이킹 지원 예정 발표
May 7 2021, 12:00 HKT
more details
MoonstakeとIOSTブロックチェーンが提携 IOSTのステーキング提供まもなく開始
MoonstakeとIOSTブロックチェーンが提携 IOSTのステーキング提供まもなく開始
May 7 2021, 12:00 HKT
more details
Moonstake Partners with IOST Blockchain, Soon to Enable Support for IOST Staking
Moonstake Partners with IOST Blockchain, Soon to Enable Support for IOST Staking
May 7 2021, 12:00 HKT
more details
复盤美股SaaS軌跡尋找十倍賽道,CRM細分龍頭訊鳥軟件(IFBD.O)成長可期
复盤美股SaaS軌跡尋找十倍賽道,CRM細分龍頭訊鳥軟件(IFBD.O)成長可期
May 6 2021, 17:03 HKT
more details
复盤美股SaaS軌跡尋找十倍賽道,CRM細分龍頭訊鳥軟件(IFBD.O)成長可期
复盤美股SaaS軌跡尋找十倍賽道,CRM細分龍頭訊鳥軟件(IFBD.O)成長可期
May 6 2021, 17:03 HKT
more details
复盘美股SaaS轨迹寻找十倍赛道,CRM细分龙头讯鸟软件(IFBD.O)成长可期
复盘美股SaaS轨迹寻找十倍赛道,CRM细分龙头讯鸟软件(IFBD.O)成长可期
May 6 2021, 17:02 HKT
more details
复盘美股SaaS轨迹寻找十倍赛道,CRM细分龙头讯鸟软件(IFBD.O)成长可期
复盘美股SaaS轨迹寻找十倍赛道,CRM细分龙头讯鸟软件(IFBD.O)成长可期
May 6 2021, 17:02 HKT
more details
NEC Develops Neuroscience-inspired AI Technology for Time Series Analysis
NEC Develops Neuroscience-inspired AI Technology for Time Series Analysis
May 6 2021, 13:13 HKT
more details
NEC Develops Neuroscience-inspired AI Technology for Time Series Analysis
NEC Develops Neuroscience-inspired AI Technology for Time Series Analysis
May 6 2021, 13:13 HKT
more details
Avance Clinical社、遺伝子技術を用いた臨床試験サービスを拡大 174億ドルの市場需要に対応
Avance Clinical社、遺伝子技術を用いた臨床試験サービスを拡大 174億ドルの市場需要に対応
May 6 2021, 13:00 HKT
more details
아방스 클리니컬, 174억 달러 규모 시장 수요를 충족하는 유전 기술 임상 시험 서비스 확대
아방스 클리니컬, 174억 달러 규모 시장 수요를 충족하는 유전 기술 임상 시험 서비스 확대
May 7 2021, 08:00 HKT
more details
Filmmakers and National TV Stations May Submit Audio-Visual Productions with Original Music, Composers, Sound Designers May Compose for Films in FMC 2021
Filmmakers and National TV Stations May Submit Audio-Visual Productions with Original Music, Composers, Sound Designers May Compose for Films in FMC 2021
May 6 2021, 16:00 HKT
more details
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand
May 7 2021, 00:00 HKT
more details
NEC Contributes to Development of Artificial DNA Aptamer that Binds to the Novel Coronavirus (SARS-CoV-2)
NEC Contributes to Development of Artificial DNA Aptamer that Binds to the Novel Coronavirus (SARS-CoV-2)
May 6 2021, 10:27 HKT
more details
NEC Contributes to Development of Artificial DNA Aptamer that Binds to the Novel Coronavirus (SARS-CoV-2)
NEC Contributes to Development of Artificial DNA Aptamer that Binds to the Novel Coronavirus (SARS-CoV-2)
May 6 2021, 10:27 HKT
more details
Fajarbaru upbeat on property segment's outlook in Malaysia and Australia
Fajarbaru upbeat on property segment's outlook in Malaysia and Australia
May 6 2021, 09:00 HKT
more details
The Place Holdings' Land Site at Mount Yuntai Tourism Township Revalued at RMB 481 Million, a Substantial Increment in Value of 329%
The Place Holdings' Land Site at Mount Yuntai Tourism Township Revalued at RMB 481 Million, a Substantial Increment in Value of 329%
May 6 2021, 07:58 HKT
more details
The Place Holdings' Land Site at Mount Yuntai Tourism Township Revalued at RMB 481 Million, a Substantial Increment in Value of 329%
The Place Holdings' Land Site at Mount Yuntai Tourism Township Revalued at RMB 481 Million, a Substantial Increment in Value of 329%
May 6 2021, 07:58 HKT
more details
The Place Holdings' Land Site at Mount Yuntai Tourism Township Revalued at RMB 481 Million, a Substantial Increment in Value of 329%
The Place Holdings' Land Site at Mount Yuntai Tourism Township Revalued at RMB 481 Million, a Substantial Increment in Value of 329%
May 6 2021, 07:58 HKT
more details
The Place Holdings' Land Site at Mount Yuntai Tourism Township Revalued at RMB 481 Million, a Substantial Increment in Value of 329%
The Place Holdings' Land Site at Mount Yuntai Tourism Township Revalued at RMB 481 Million, a Substantial Increment in Value of 329%
May 6 2021, 07:58 HKT
more details
The Place Holdings' Land Site at Mount Yuntai Tourism Township Revalued at RMB 481 Million, a Substantial Increment in Value of 329%
The Place Holdings' Land Site at Mount Yuntai Tourism Township Revalued at RMB 481 Million, a Substantial Increment in Value of 329%
May 6 2021, 07:58 HKT
more details
HKTDC's Start-up Fiesta kick-starts today
HKTDC's Start-up Fiesta kick-starts today
May 5 2021, 19:00 HKT
more details
HKTDC's Start-up Fiesta kick-starts today
HKTDC's Start-up Fiesta kick-starts today
May 5 2021, 19:00 HKT
more details
HKTDC's Start-up Fiesta kick-starts today
HKTDC's Start-up Fiesta kick-starts today
May 5 2021, 19:00 HKT
more details
中信国际电讯CPC凭借「DataHOUSE AR 千里眼」于「2021年度新加坡商业评论 - 卓越科技奖 (SBR TEA 2021)」中荣膺「电讯业增强现实及虚拟现实项目(Augmented & Virtual Reality Award for Telecommunications)」奖项
中信国际电讯CPC凭借「DataHOUSE AR 千里眼」于「2021年度新加坡商业评论 - 卓越科技奖 (SBR TEA 2021)」中荣膺「电讯业增强现实及虚拟现实项目(Augmented & Virtual Reality Award for Telecommunications)」奖项
May 5 2021, 12:30 HKT
more details
中信國際電訊CPC憑「DataHOUSE AR 千里眼」於「2021年度新加坡商業評論 - 卓越科技獎 (SBR TEA 2021)」中榮膺「電訊業擴增實境及虛擬現實項目(Augmented & Virtual Reality Award for Telecommunications)」獎項
中信國際電訊CPC憑「DataHOUSE AR 千里眼」於「2021年度新加坡商業評論 - 卓越科技獎 (SBR TEA 2021)」中榮膺「電訊業擴增實境及虛擬現實項目(Augmented & Virtual Reality Award for Telecommunications)」獎項
May 5 2021, 12:30 HKT
more details
CITIC Telecom CPC's DataHOUSE AR Remote Hand wins Augmented & Virtual Reality Award for Telecommunications at SBR TEA 2021
CITIC Telecom CPC's DataHOUSE AR Remote Hand wins Augmented & Virtual Reality Award for Telecommunications at SBR TEA 2021
May 5 2021, 12:30 HKT
more details
花旗:给予贝康医疗(2170.HK)「买入」评级,目标价40港元
花旗:给予贝康医疗(2170.HK)「买入」评级,目标价40港元
May 5 2021, 11:00 HKT
more details
花旗:给予贝康医疗(2170.HK)「买入」评级,目标价40港元
花旗:给予贝康医疗(2170.HK)「买入」评级,目标价40港元
May 5 2021, 11:00 HKT
more details
 ACN Search:
 
TrustCSI 3.0 Navigates the 'Belt and Road' and Empowers Global Enterprise's Digital Journey
 
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575